1. Home
  2. AGRO vs ATAI Comparison

AGRO vs ATAI Comparison

Compare AGRO & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adecoagro S.A.

AGRO

Adecoagro S.A.

HOLD

Current Price

$12.66

Market Cap

1.5B

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.55

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGRO
ATAI
Founded
2002
2018
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2011
2025

Fundamental Metrics

Financial Performance
Metric
AGRO
ATAI
Price
$12.66
$4.55
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
$12.80
$15.88
AVG Volume (30 Days)
1.6M
6.3M
Earning Date
05-11-2026
05-11-2026
Dividend Yield
2.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,089,000.00
Revenue This Year
$45.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$37.52
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$6.89
$1.29
52 Week High
$15.89
$6.73

Technical Indicators

Market Signals
Indicator
AGRO
ATAI
Relative Strength Index (RSI) 45.17 62.74
Support Level $7.67 $3.41
Resistance Level $15.89 $4.68
Average True Range (ATR) 0.74 0.31
MACD -0.29 0.10
Stochastic Oscillator 24.65 51.93

Price Performance

Historical Comparison
AGRO
ATAI

About AGRO Adecoagro S.A.

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: